Literature DB >> 18841370

Ankylosing spondylitis in a patient with myelodysplastic syndrome: an association with HLA-B27 or coincidence?

Jaejoon Lee1, Hyungjin Kim, Joong Kyong Ahn, Ji Won Hwang, Jun Ho Jang, Eun-Mi Koh, Hoon-Suk Cha.   

Abstract

The authors report an unusual case of myelodysplastic syndrome (MDS) associated with ankylosing spondylitis (AS). A 40-year-old-man with MDS presented with chronic low back pain for 6 years. Four years ago, MDS was diagnosed during routine blood analysis for the work-up of his articular complaints. His initial articular complaints were attributed to extramedullary manifestations of MDS. Persistent low back pain with increasing intensity finally led the patient to seek medical attention. Radiograph of the pelvis showed bilateral asymmetric sacroiliitis. A diagnosis of AS was established on the basis of modified New York criteria. Although various autoimmune phenomena associated with MDS have been described, this is the first report of AS in the setting of MDS. Causal relationship between these two disorders is currently unknown. Increased risk of hematological diseases as well as AS in individuals with a positive HLA-B27 provides a feasible explanation for this rare observation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18841370     DOI: 10.1007/s00296-008-0735-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  10 in total

Review 1.  Rheumatic manifestations in myelodysplastic syndromes.

Authors:  M Castro; D L Conn; W P Su; J P Garton
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

2.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

3.  The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population.

Authors:  S M van der Linden; H A Valkenburg; B M de Jongh; A Cats
Journal:  Arthritis Rheum       Date:  1984-03

Review 4.  Myelodysplastic syndromes.

Authors:  D C Doll; A F List
Journal:  West J Med       Date:  1989-08

5.  Sacroiliitis as an initial manifestation of acute myelogenous leukemia.

Authors:  Takumi Hoshino; Takafumi Matsushima; Yasuyuki Saitoh; Arito Yamane; Makiko Takizawa; Hiroyuki Irisawa; Takayuki Saitoh; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

6.  Risk of haematological malignancies in HLA-B27 carriers.

Authors:  W Y Au; B R Hawkins; N Cheng; A K Lie; R Liang; Y L Kwong
Journal:  Br J Haematol       Date:  2001-11       Impact factor: 6.998

7.  Myelodysplastic syndrome associated with relapsing polychondritis: unusual transformation from refractory anemia to chronic myelomonocytic leukemia.

Authors:  T Shirota; O Hayashi; H Uchida; N Tonozuka; N Sakai; H Itoh
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

8.  Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.

Authors:  H Enright; H S Jacob; G Vercellotti; R Howe; M Belzer; W Miller
Journal:  Br J Haematol       Date:  1995-10       Impact factor: 6.998

9.  Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8.

Authors:  J K Ahn; H-S Cha; E-M Koh; S-H Kim; Y G Kim; C-K Lee; B Yoo
Journal:  Rheumatology (Oxford)       Date:  2008-06-11       Impact factor: 7.580

10.  Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study.

Authors:  S Giannouli; M Voulgarelis; E Zintzaras; A G Tzioufas; H M Moutsopoulos
Journal:  Rheumatology (Oxford)       Date:  2004-02-24       Impact factor: 7.580

  10 in total
  3 in total

Review 1.  Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.

Authors:  Omar Al Ustwani; Laurie A Ford; Sheila J N Sait; Anne Marie W Block; Maurice Barcos; Carlos E Vigil; Elizabeth A Griffiths; James E Thompson; Eunice S Wang; Julian Ambrus; Meir Wetzler
Journal:  Leuk Res       Date:  2013-05-18       Impact factor: 3.156

2.  Human Leukocyte Antigen-B27: The Genetic Predisposition Leading to Reactive Arthritis during Induction Phase Chemotherapy for Acute Myeloid Leukemia.

Authors:  Sandip P Bartakke; Abhilasha Ashok Sampagar; Vibha Sanjay Bafna; Putun Patel
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jul-Sep

3.  Concurrent ankylosing spondylitis and myelodysplastic syndrome: A case report.

Authors:  Guan-Hua Xu; Jin Lin; Wei-Qian Chen
Journal:  World J Clin Cases       Date:  2022-02-26       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.